135 related articles for article (PubMed ID: 6982243)
1. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells.
Müller WE; Schuster DK; Zahn RK; Maidhof A; Leyhausen G; Falke D; Koren R; Umezawa H
Int J Immunopharmacol; 1982; 4(5):393-400. PubMed ID: 6982243
[TBL] [Abstract][Full Text] [Related]
2. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin.
Leyhausen G; Schuster DK; Vaith P; Zahn RK; Umezawa H; Falke D; Müller WE
Biochem Pharmacol; 1983 Mar; 32(6):1051-7. PubMed ID: 6838651
[TBL] [Abstract][Full Text] [Related]
3. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ
Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860
[TBL] [Abstract][Full Text] [Related]
4. The slow, tight binding of bestatin and amastatin to aminopeptidases.
Wilkes SH; Prescott JM
J Biol Chem; 1985 Oct; 260(24):13154-62. PubMed ID: 2865258
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic effect of bestatin on lymphocytes.
Ishizuka M; Sato J; Sugiyama Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Jun; 33(6):653-62. PubMed ID: 7419476
[TBL] [Abstract][Full Text] [Related]
7. Bestatin, an inhibitor of aminopeptidase B, suppresses the proliferation and differentiation of human B-cells in vitro.
Morikawa K; Morikawa S; Nakano A; Oseko F
Int J Immunopharmacol; 1989; 11(8):905-13. PubMed ID: 2613395
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
Taylor A; Peltier CZ; Torre FJ; Hakamian N
Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
[TBL] [Abstract][Full Text] [Related]
10. Bestatin, a stimulator of polysome assembly in T cell lymphoma (L 5178y).
Muller WE; Zahn RK; Maidhof A; Schroder HC; Umezawa H
Biochem Pharmacol; 1981 Dec; 30(24):3375-7. PubMed ID: 7326051
[No Abstract] [Full Text] [Related]
11. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
[TBL] [Abstract][Full Text] [Related]
12. Induction of DNA polymerase alpha and terminal deoxynucleotidyl transferase in the human lymphoblastoid cell line Molt-4 by the immunomodulator bestatin.
Leyhausen G; Dippold W; Zahn RK; Meyer zum Büschenfelde KH; Umezawa H; Müller WE
Immunopharmacology; 1984 Jun; 7(3-4):151-7. PubMed ID: 6590537
[TBL] [Abstract][Full Text] [Related]
13. An aminopeptidase inhibitor, bestatin, enhances progesterone and oestradiol secretion by porcine granulosa cells stimulated with follicle stimulating hormone in vitro.
Tachibana T; Fujiwara H; Suginami H; Nakamura K; Honda T; Yamada S; Maeda M; Mori T
Hum Reprod; 1996 Mar; 11(3):497-502. PubMed ID: 8671253
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical identification of the cell surface bound leucine aminopeptidase, the target enzyme for the immunostimulant bestatin.
Leyhausen G; Gramzow M; Zahn RK; Steffen R; Umezawa H; Müller WE
J Antibiot (Tokyo); 1983 Jun; 36(6):728-34. PubMed ID: 6348011
[TBL] [Abstract][Full Text] [Related]
15. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
16. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of a membrane-bound enkephalin-degrading aminopeptidase by bestatin analogs.
Shimamura M; Hazato T; Hachisu M; Katayama T
J Neurochem; 1984 Sep; 43(3):888-90. PubMed ID: 6431055
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of arginine aminopeptidase by bestatin and arphamenine analogues. Evidence for a new mode of binding to aminopeptidases.
Harbeson SL; Rich DH
Biochemistry; 1988 Sep; 27(19):7301-10. PubMed ID: 3207677
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of sulfur-containing analogues of bestatin. Inhibition of aminopeptidases by alpha-thiolbestatin analogues.
Ocain TD; Rich DH
J Med Chem; 1988 Nov; 31(11):2193-9. PubMed ID: 3184126
[TBL] [Abstract][Full Text] [Related]
20. Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with Bestatin.
Noma T; Klein B; Cupissol D; Yata J; Serrou B
Int J Immunopharmacol; 1984; 6(2):87-92. PubMed ID: 6429060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]